Upgrade to SI Premium - Free Trial

Passage Bio (PASG)

5.59 +0.26 (4.88%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Guggenheim Downgrades Passage Bio Inc. (PASG) to Neutral June 10, 2026 6:47 AM - StreetInsider Passage Bio terminates collaboration deal, exits office lease May 27, 2026 4:19 PM - StreetInsider Form 8-K Passage BIO, Inc. For: May 21 May 27, 2026 4:16 PM - SEC Filing Form 8-K Passage BIO, Inc. For: May 19 May 26, 2026 7:15 AM - SEC Filing Form 4 Passage BIO, Inc. For: May 19 Filed by: Sondhi Dolan May 21, 2026 4:14 PM - SEC Filing Form 4 Passage BIO, Inc. For: May 19 Filed by: Porter Derrell May 21, 2026 4:14 PM - SEC Filing Form 4 Passage BIO, Inc. For: May 19 Filed by: Kassberg Thomas Richard May 21, 2026 4:13 PM - SEC Filing Form 4 Passage BIO, Inc. For: May 19 Filed by: Kapadia Sandip May 21, 2026 4:12 PM - SEC Filing Form 4 Passage BIO, Inc. For: May 19 Filed by: GOWEN MAXINE May 21, 2026 4:11 PM - SEC Filing Form 4 Passage BIO, Inc. For: May 19 Filed by: Countouriotis Athena May 21, 2026 4:11 PM - SEC Filing Form 10-Q Passage BIO, Inc. For: Mar 31 May 12, 2026 7:02 AM - SEC Filing Form 8-K Passage BIO, Inc. For: Apr 28 April 28, 2026 7:01 AM - SEC Filing TD Cowen Downgrades Passage Bio Inc. (PASG) to Hold April 21, 2026 9:04 AM - StreetInsider Passage Bio Inc. (PASG) PT Lowered to $15 at Oppenheimer April 21, 2026 7:06 AM - StreetInsider Wedbush Downgrades Passage Bio Inc. (PASG) to Neutral April 21, 2026 6:56 AM - StreetInsider Chardan Downgrades Passage Bio Inc. (PASG) to Neutral April 21, 2026 3:20 AM - StreetInsider Lucid Capital Markets Downgrades Passage Bio Inc. (PASG) to Neutral April 20, 2026 9:02 AM - StreetInsider Form 8-K Passage BIO, Inc. For: Apr 20 April 20, 2026 7:16 AM - SEC Filing Passage Bio reports interim trial data, initiates strategic review April 20, 2026 7:03 AM - StreetInsider Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates April 20, 2026 7:00 AM - StreetInsider Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates April 20, 2026 7:00 AM - Globe NewsWire Form ARS Passage BIO, Inc. For: Dec 31 April 7, 2026 12:43 PM - SEC Filing Form DEFA14A Passage BIO, Inc. April 7, 2026 12:43 PM - SEC Filing Form DEF 14A Passage BIO, Inc. For: May 19 April 7, 2026 12:42 PM - SEC Filing Baird Starts Passage Bio Inc. (PASG) at Outperform March 31, 2026 2:12 AM - StreetInsider Oppenheimer Starts Passage Bio Inc. (PASG) at Outperform March 30, 2026 4:02 PM - StreetInsider Full Article List